The ADDF is shaping and leading the science to bring us what comes next.

Annual Report 2024

year of the blood test
Down arrow, scroll to next section
From Our Founders
Leonard Lauder
Ronald Lauder
From Our Founders
Dear Friends,

We founded the Alzheimer’s Drug Discovery Foundation (ADDF) in honor of our mother, Estée Lauder, because we saw firsthand the urgent need for treatments. This is a disease that affects not only the patient, but entire families – millions of them around the globe. And we are making remarkable headway. The level of progress we have seen in 2024 is truly unprecedented, and it is an honor to lead an organization that is transforming the landscape and bringing hope to those in need.

For the first time in history, we have multiple effective drugs available to help Alzheimer’s patients. And the ADDF continues to drive this momentum forward; advancing novel therapeutics, better ways to diagnose the disease, and prevention methods; thanks in large part to the leadership of our brilliant Co-Founder and Chief Science Officer, Dr. Howard Fillit, and the many innovative scientists we support.

We were thrilled to honor the impact of several of these scientists in Stockholm during a special celebration for the tenth anniversary of the ADDF’s Melvin R. Goodes Prize, which each year recognizes a pioneering researcher who has made an exceptional impact on the Alzheimer's field. The city’s tradition of recognizing brilliance through the Nobel Prize made it the perfect place to celebrate the Goodes Prize as it marked a decade of accelerating innovation, enabling breakthroughs, and shaping Alzheimer's science.

From the beginning, the ADDF’s unique structure has positioned us to propel the science towards the future of treatment. Our venture philanthropy model allows us to ensure each of our successes builds upon the others, with any returns re-invested into new ideas that will lead to the next breakthrough. And our board, which we expanded over the past year, convenes key thought leaders from industry, academia, business, and philanthropy who provide critical insights and expertise to help us conquer this disease.

It is an honor to work with them, as well as with our many dedicated partners, including Bill Gates, the Dolby family, the Foundation for a Better World, and the Shanahan Family Foundation. And of course, we could not fulfill our mission without our incredible donors.

We are confident that, together, we will soon create a world where no family has to worry about Alzheimer's.

With our gratitude,

Signature of Leonard A. Lauder
Leonard A. Lauder
Co-Chairman and Co-Founder
Signature of Ronald S. Lauder
Ronald S. Lauder
Co-Chairman and Co-Founder
From Our Executive Leadership
Howard Fillit
Mark Roithmayr
From Our Executive Leadership
Dear Friends,

It has been another incredible year for the Alzheimer’s field, with the Alzheimer's Drug Discovery Foundation (ADDF) at the helm, shaping and leading the science.

With the help of our donors, partners, and funded researchers, we are revolutionizing treatment and driving the field toward the ultimate goal of combination therapies and precision medicine, the same approach that has proven successful for cancer. And we could not be prouder of the progress being made.

This has been a landmark year for diagnostics, led by ADDF-funded companies – so much so that we have called it “the year of the blood test.” C2N Diagnostics, ALZpath, and Fujirebio all announced new data and partnerships, moving us closer to the day when blood tests could replace PET scans and CSF tests as a more accessible first line of defense in diagnosis than ever before.

We have also seen great strides in drug development with another anti-amyloid therapy, Kisunla, approved. This adds to the first class of Alzheimer’s drugs, for which the ADDF-funded Amyvid PET scan paved the way. And we have continued to advance the next generation of treatments informed by the biology of aging, even convening an advisory board of experts to provide critical guidance for future clinical trials focused on combination therapies.

The ADDF’s renowned worldwide network of scientists allows us to build on our momentum year after year and speed effective treatments toward the patients who need them. We are honored to play a leading role in facilitating global collaboration between the brightest minds in the Alzheimer’s field. This September, we had the privilege of being joined by Her Majesty Queen Silvia of Sweden and U.S. Ambassador to Sweden Erik Ramanathan as we convened our esteemed international group of Goodes Prize winners in Stockholm.

With the continued growth and flourishing of our partnerships, the leadership of our visionary co-founders Leonard A. and Ronald S. Lauder, and the dedication of all our supporters, we will continue to build upon this year’s breakthroughs and advance the science until we have stopped this disease in its tracks.

Many thanks,

Signature of Howard Fillit
Howard Fillit, MD
Co-Founder and Chief Science Officer
Signature of Mark Roithmayr
Mark Roithmayr
Chief Executive Officer
Dear Friends,

We founded the Alzheimer’s Drug Discovery Foundation (ADDF) in honor of our mother, Estée Lauder, because we saw firsthand the urgent need for treatments. This is a disease that affects not only the patient, but entire families – millions of them around the globe. And we are making remarkable headway. The level of progress we have seen in 2024 is truly unprecedented, and it is an honor to lead an organization that is transforming the landscape and bringing hope to those in need.

For the first time in history, we have multiple effective drugs available to help Alzheimer’s patients. And the ADDF continues to drive this momentum forward; advancing novel therapeutics, better ways to diagnose the disease, and prevention methods; thanks in large part to the leadership of our brilliant Co-Founder and Chief Science Officer, Dr. Howard Fillit, and the many innovative scientists we support.

We were thrilled to honor the impact of several of these scientists in Stockholm during a special celebration for the tenth anniversary of the ADDF’s Melvin R. Goodes Prize, which each year recognizes a pioneering researcher who has made an exceptional impact on the Alzheimer's field. The city’s tradition of recognizing brilliance through the Nobel Prize made it the perfect place to celebrate the Goodes Prize as it marked a decade of accelerating innovation, enabling breakthroughs, and shaping Alzheimer's science.

From the beginning, the ADDF’s unique structure has positioned us to propel the science towards the future of treatment. Our venture philanthropy model allows us to ensure each of our successes builds upon the others, with any returns re-invested into new ideas that will lead to the next breakthrough. And our board, which we expanded over the past year, convenes key thought leaders from industry, academia, business, and philanthropy who provide critical insights and expertise to help us conquer this disease.

It is an honor to work with them, as well as with our many dedicated partners, including Bill Gates, the Dolby family, the Foundation for a Better World, and the Shanahan Family Foundation. And of course, we could not fulfill our mission without our incredible donors.

We are confident that, together, we will soon create a world where no family has to worry about Alzheimer's.

With our gratitude,

Leonard Lauder
Ronald Lauder
Signature of Leonard A. Lauder
Leonard A. Lauder
Co-Chairman and Co-Founder
Signature of Ronald S. Lauder
Ronald S. Lauder
Co-Chairman and Co-Founder
Dear Friends,

It has been another incredible year for the Alzheimer’s field, with the Alzheimer's Drug Discovery Foundation (ADDF) at the helm, shaping and leading the science.

With the help of our donors, partners, and funded researchers, we are revolutionizing treatment and driving the field toward the ultimate goal of combination therapies and precision medicine, the same approach that has proven successful for cancer. And we could not be prouder of the progress being made.

This has been a landmark year for diagnostics, led by ADDF-funded companies – so much so that we have called it “the year of the blood test.” C2N Diagnostics, ALZpath, and Fujirebio all announced new data and partnerships, moving us closer to the day when blood tests could replace PET scans and CSF tests as a more accessible first line of defense in diagnosis than ever before.

We have also seen great strides in drug development with another anti-amyloid therapy, Kisunla, approved. This adds to the first class of Alzheimer’s drugs, for which the ADDF-funded Amyvid PET scan paved the way. And we have continued to advance the next generation of treatments informed by the biology of aging, even convening an advisory board of experts to provide critical guidance for future clinical trials focused on combination therapies.

The ADDF’s renowned worldwide network of scientists allows us to build on our momentum year after year and speed effective treatments toward the patients who need them. We are honored to play a leading role in facilitating global collaboration between the brightest minds in the Alzheimer’s field. This September, we had the privilege of being joined by Her Majesty Queen Silvia of Sweden and U.S. Ambassador to Sweden Erik Ramanathan as we convened our esteemed international group of Goodes Prize winners in Stockholm.

With the continued growth and flourishing of our partnerships, the leadership of our visionary co-founders Leonard A. and Ronald S. Lauder, and the dedication of all our supporters, we will continue to build upon this year’s breakthroughs and advance the science until we have stopped this disease in its tracks.

Many thanks,

Howard Fillit
Mark Roithmayr
Signature of Howard Fillit
Howard Fillit, MD
Co-Founder and Chief Science Officer
Signature of Mark Roithmayr
Mark Roithmayr
Chief Executive Officer
$
360
M
INVESTED IN SCIENCE
Microscope with lab equipmentMicroscope with lab equipment
763
projects funded
Hand holding a pillHand holding a pill
21
Countries with Funded Research
Scientist working in a laboratoryScientist working in a laboratory

Shaping the
Next Generation of
Therapeutics

At the ADDF, we are dedicated to driving the science toward combination therapies and precision medicine, which will be key to stopping Alzheimer's in its tracks. We have built a legacy as leaders in therapeutic innovation over the past 26 years, pioneering a biology of aging approach which now informs nearly 75% of drugs in development. And we will continue to push the field forward until we have effective treatments for all of the patients and families who need them.

Read More
Two scientists collaborating in a laboratory
Gloved hand pulling a blood vial from a rack in a lab.

Leading Development
of Cutting-Edge
Diagnostics

2024 has been a year of breakthroughs for Alzheimer’s blood tests, with ADDF-funded companies leading the charge. Our Diagnostics Accelerator initiative, founded in partnership with Bill Gates, has been at the forefront of biomarker development since its inception. As the tools funded through this program advance, they are revolutionizing the way we diagnose and treat Alzheimer’s disease. Soon, we will have eye scans and digital tools to use alongside these blood tests, further transforming the course of this disease.

Read More

Paving the Way
for Precision
Prevention

Our ultimate goal is not only to treat Alzheimer’s, but to prevent it before it begins. The ADDF is forging the path for a precision prevention approach that will look at therapeutic and lifestyle interventions in tandem, tailoring them for individual patients. We have partnered with global leaders in the prevention space to ensure we are at the cutting-edge of developing solutions. And through our Cognitive Vitality website, we continue to provide our audiences with the latest recommendations on preserving brain health.

Read more
Doctor using a tablet in a clinic.

See New and Continuing Programs

Download PDF
Scientists collaborating on data analysis at a computer in a laboratoryScientists collaborating on data analysis at a computer in a laboratory.
Melvin R. Goodes
Watch Video

Honoring the Impact of the Goodes Prize

We were thrilled to bring together our friends and supporters, along with key scientific, government, and industry leaders for a special three-day celebration honoring the 10th anniversary of the Melvin R. Goodes Prize. Each year, this prize recognizes a trailblazing scientist who has helped to revolutionize the Alzheimer's field, so it was only fitting to hold our celebration in Stockholm, Sweden, a city with deep scientific roots and the home of the Nobel Prize. The 2024 prize was presented to Dr. Henrik Zetterberg, a world leader in Alzheimer’s biomarkers.

The Goodes Prize exemplifies the global collaboration fostered by the ADDF as we shape and lead the science toward the ultimate goal of combination therapies and precision medicine. It was an honor to be joined by both Her Majesty Queen Silvia of Sweden and U.S. Ambassador to the Kingdom of Sweden Erik Ramanathan, who declared the Goodes Prize "the Nobel Prize of Alzheimer's research."

We are grateful to have been able to honor the legacy of Mel Goodes, the visionary philanthropist and pharmaceutical executive for whom the prize was named, in the presence of his wife Nancy before his passing just three weeks after the event. Nancy and Mel’s combined vision and efforts in establishing the Goodes Prize have made a profound impact on the entire Alzheimer's field and Mel’s legacy will live on through the breakthroughs made by the pioneering recipients of this award.

Thought Leadership

At the ADDF, we are honored to play a leading role in conferences and summits across the U.S. and abroad. We use our role to foster global collaboration, shape agendas to ensure resources are funneled in the right directions, and drive progress in critical therapeutic, diagnostic, and prevention research. Notably, our co-founder Ronald S. Lauder was joined by Michael J. Fox for the inaugural fireside chat at this year’s International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD), exploring the significant role of philanthropy in driving Alzheimer’s research and innovation.

We also act as conveners of leading voices in the field, both through our signature event panels and our Tomorrow’s Breakthroughs Today Scientific Symposium Series, founded in partnership with Heidi and Tom McWilliams, which brings together world-class scientists each year to discuss the path toward new treatments. In 2024, we also expanded our board, adding further experts from industry, academia, business, and philanthropy to provide critical insights and expertise that uniquely position us to tackle Alzheimer’s.

2024 Thought Leadership & Conferences

US Locations
European Locations
San FranciscoSan Francisco
Palm Beach, FloridaPalm Beach, Florida
Albuquerque, New MexicoAlbuquerque, New Mexico
San Diego, CaliforniaSan Diego, California
New York, New YorkNew York, New York
Philadelphia, PennsylvaniaPhiladelphia, Pennsylvania
Cambridge, MassachusettsCambridge, Massachusetts
United States
Click on a city to see more details.
Lisbon, PortugalLisbon, Portugal
London, EnglandLondon, England
Warsaw, PolandWarsaw, Poland
Stockholm, SwedenStockholm, Sweden
Madrid, SpainMadrid, Spain
EU map
Click on a city to see more details.
Click on a city to see more details.
San Francisco, CA
J. P. Morgan Healthcare Conference
January 2024
BIO Investor Forum
October 2024
Palm Beach, FL
Tomorrow’s Breakthroughs Today Scientific Symposium Series
January 2024
February 2024
April 2024
Albuquerque, NM
Geroscience Translational Clinical Trials ICFSR Task Force
March 2024
San Diego, CA
BIO International Convention
June 2024
New York, NY
Pre-AAIC Partner Meeting
July 2024
BioFuture
October 2024
Philadelphia, PA
Alzheimer’s Association International Conference (AAIC)
July 2024
Cambridge, MA
Lab Central Mind Matters Science Symposium
November 2024
Lisbon, Portugal
International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD)
March 2024
London, England
World Dementia Council Summit
March 2024
Warsaw, Poland
Alzheimer’s Disease International (ADI) Conference
April 2024
Stockholm, Sweden
Goodes Prize 10th Anniversary Celebration
September 2024
Madrid, Spain
Clinical Trials on Alzheimer’s Disease (CTAD) Conference
October 2024

Select Media Highlights

As we continue to see ADDF support drive innovation, the voices of our funded researchers and our Co-Founder and Chief Science Officer Dr. Howard Fillit are being sought by top media outlets to help guide the scientific narrative.

An Alzheimer’s Advance, Not a Cure-All

In his op-ed, ADDF Co-Founder and Chief Science Officer Dr. Howard Fillit elucidates why amyloid-targeting drugs should be viewed as building blocks for the next generation of Alzheimer’s care, rather than a panacea. Ultimately, we will need an arsenal of drugs guided by the biology of aging to treat Alzheimer's disease.

Dr. Fillit on Eli Lilly’s Alzheimer’s Drug: Really Having Breakthroughs and Success for the First Time

Dr. Fillit shared his expert opinion with the anchors of CNBC’s Squawk Box following the FDA Advisory Committee meeting on whether to approve Kisunla (donanemab) earlier this year. He highlights the need for combination therapies and precision medicine akin to cancer care to stop Alzheimer’s in its tracks.

The Next Potential Alzheimer’s Drug Clears a Big Hurdle

This article, which focuses on the approval process for Kisunla (donanemab), closes with a quote from Dr. Fillit, with his commentary serving as the bottom line on what this first class of amyloid-targeting drugs can offer and where the field is going next.

New Blood Tests Can Help Diagnose Alzheimer’s. Are Doctors Ready for What's Next?

Dr. Fillit weighs in on the importance of blood tests for Alzheimer's diagnosis, offering guidance for the field by noting that as physicians learn how to more quickly diagnose patients with the help of these tests, it is crucial that they use this reclaimed time to do the necessary counseling and education.

Alzheimer’s Patients and Their Families Hear a New Word: Progress

This article demonstrates the impact of the ADDF’s scientific approach, spotlighting three of our funded researchers, highlighting Dr. Fillit’s commentary, and reflecting the strategy we have pioneered: uniting combination therapies, biomarkers, and prevention methods to defeat Alzheimer's disease.

Stewardship

Seventh Annual Hope on the Horizon Palm Beach Dinner

Our annual Palm Beach event honored Nancy Goodes, board member and longtime friend of the ADDF, for her extraordinary leadership and the impact she and her late husband Mel have made on Alzheimer’s science through the Goodes Prize. We were also delighted to feature Dr. Rhoda Au, our 2023 Goodes Prize winner, for a scientific symposium touching on her work as a leader in digital biomarkers.

CLICK ON IMAGES FOR MORE INFO
TAP IMAGES FOR MORE INFO
Judy Glickman Lauder and Leonard A. LauderTom McWilliams, Heidi McWilliams, Nancy Goodes, and Mark RoithmayrBonnie Englebardt Lautenberg and Nancy Goodes
Judy Glickman Lauder and Leonard A. LauderTom McWilliams, Heidi McWilliams, Nancy Goodes, and Mark Roithmayr
Bonnie Englebardt Lautenberg and Nancy Goodes

Stewardship

Seventh Annual Memories Matter

Hosted at the American Museum of Natural History, the event brought together over 500 people to celebrate and support groundbreaking Alzheimer’s research. Memories Matter co-founders Stephanie Ginsberg and Wendy Wilshin gave heartfelt speeches about their families’ journeys with Alzheimer’s and their optimism as the ADDF continues to shape the future of treatment.

CLICK ON IMAGES FOR MORE INFO
TAP IMAGES FOR MORE INFO
Ian Ginsberg, Stephanie Ginsberg, Wendy Wilshin, and Ron DickermanHope Altheim, Stephanie Ginsberg, and Cindy TellNicole Reinsberg Kubin, Wendy Wilshin, Jamie Seidner, and Jonathan Rubin
Ian Ginsberg, Stephanie Ginsberg, Wendy Wilshin, and Ron DickermanHope Altheim, Stephanie Ginsberg, and Cindy Tell
Nicole Reinsberg Kubin, Wendy Wilshin, Jamie Seidner, and Jonathan Rubin

Stewardship

Fourteenth Annual Great Ladies Luncheon and Fashion Show

Our annual celebration of science and fashion honored Charlie Lefkowitz Crowley with the Estelle Gelman Award and Kristin Rae Cecchi with the Great Ladies Award. The program also included a special fashion show spotlighting designs by Carolina Herrera in collaboration with our fashion partner Saks and a scientific symposium, sponsored by Eli Lilly and featuring Anne White, President of Lilly Neuroscience.

CLICK ON IMAGES FOR MORE INFO
TAP IMAGES FOR MORE INFO
Andrea Mitchell, Howard Fillit, and Anne WhiteMark Roithmayr, Charlie Lefkowitz Crowley, Wes Gordon, Kristin Rae Cecchi, Anne White, and Howard FillitMarc and Elise Lefkowitz
Andrea Mitchell, Howard Fillit, and Anne WhiteMark Roithmayr, Charlie Lefkowitz Crowley, Wes Gordon, Kristin Rae Cecchi, Anne White, and Howard Fillit
Marc and Elise Lefkowitz

Stewardship

Tenth Annual Melvin R. Goodes Prize

Held in Stockholm Sweden, this special three-day event celebrated the impact of the Goodes Prize and its recipients over the past decade. The program included a full day of cutting-edge science attended by Her Majesty Queen Silvia of Sweden and a dinner at Stockholm City Hall, home of the annual Nobel Prize banquet, where U.S. Ambassador to the Kingdom of Sweden, Erik Ramanathan, presented medals to all ten Goodes Prize scientists, including our 2024 recipient, Dr. Henrik Zetterberg.

CLICK ON IMAGES FOR MORE INFO
TAP IMAGES FOR MORE INFO
Gary Lauder and Howard Fillit(Back row) D. Martin Watterson, Jeff Cummings, Jerri Rook, Miia Kivipelto, (front row) Frank Longo, Roberta Diaz Brinton, Howard Fillit, Nancy Goodes, Gary Lauder, Randal Sandler, Henrik Zetterberg, Miranda Orr, and Rhoda AuHer Majesty Queen Silvia of Sweden
Gary Lauder and Howard Fillit(Back row) D. Martin Watterson, Jeff Cummings, Jerri Rook, Miia Kivipelto, (front row) Frank Longo, Roberta Diaz Brinton, Howard Fillit, Nancy Goodes, Gary Lauder, Randal Sandler, Henrik Zetterberg, Miranda Orr, and Rhoda Au
Her Majesty Queen Silvia of Sweden

Stewardship

Fourteenth Annual Fall Symposium and Luncheon

The event honored The Goodnow Fund with the Charles Evans Award, in recognition of Ned Goodnow and his family’s significant support of Alzheimer’s research, and Biogen with the Visionary Partner Award for its dedication to furthering Alzheimer's science. The symposium centered on innovative biomarker development and featured Dr. Joel Braunstein, Co-Founder and CEO of C2N Diagnostics; Dr. Danielle Graham, VP and Head of Biomarkers at Biogen; and Dr. Russ Lebovitz, CEO of Amprion.

CLICK ON IMAGES FOR MORE INFO
TAP IMAGES FOR MORE INFO
Mark Roithmayr, Rachid Izzar, and Carl GoodnowJosh Lauder and William LauderHoward Fillit, Ronald S. Lauder, Paula Zahn, and Mark Roithmayr
Josh Lauder and William LauderMark Roithmayr, Rachid Izzar, and Carl Goodnow
Howard Fillit, Ronald S. Lauder, Paula Zahn, and Mark Roithmayr

Stewardship

Third Annual House of Purple

Led by the ADDF’s Young Professionals Committee (YPC), made up of the next generation of Alzheimer’s advocates, the fun and hopeful event honored Audrey Peterson with the Outstanding Volunteer Award for her steadfast support of both the YPC and the ADDF’s mission. Audrey shared her family’s personal connection to the disease in a heartwarming and inspiring speech.

CLICK ON IMAGES FOR MORE INFO
TAP IMAGES FOR MORE INFO
Josh Lauder, Gina Holzheimer, Audrey Peterson, Lizzie Toma, Michelle Florin, and Aaron HoytJosh Lauder, Katherine Lauder, Laura Lauder, and Gary LauderDrew Berube, Madelyn Peterson Berube, Scott Peterson, Audrey Peterson, Teresa Carballo-Peterson, Mark Roithmayr
Josh Lauder, Gina Holzheimer, Audrey Peterson, Lizzie Toma, Michelle Florin, and Aaron HoytJosh Lauder, Katherine Lauder, Laura Lauder, and Gary Lauder
Drew Berube, Madelyn Peterson Berube, Scott Peterson, Audrey Peterson, Teresa Carballo-Peterson, Mark Roithmayr

Friendship

We are deeply grateful to all those who supported our work in 2024. Your generosity gives us hope for a future without Alzheimer’s disease.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
The ADDF is profoundly grateful to Leonard A. Lauder, Ronald S. Lauder, William Lauder, Gary Lauder, Aerin Lauder Zinterhofer, and Jane Lauder for their historic $200 million gift. Thanks to their visionary philanthropy, every dollar donated to the ADDF goes directly to innovative science.
§
Anonymous (3)
Association for Frontotemporal Degeneration
Dagmar Dolby Fund
Natasha and David Dolby
Bonnie Englebardt Lautenberg, Lois Robbins, and Carol Weisman
Foundation for a Better World
Gates Ventures
JTMF Foundation
Aerin Lauder Zinterhofer and Eric Zinterhofer
Jane Lauder and Kevin Warsh
Jo Carole and Ronald S. Lauder
Judy and Leonard A. Lauder
Laura and Gary Lauder
William P. Lauder
Susan and Donald Newhouse
NKMax Co., Ltd.
Pershing Square Philanthropies
Catherine and Michael Podell
Samuel I. Newhouse Foundation, Inc.
Lizabeth and Randal Sandler
Shanahan Family Foundation
Sorry, no donors found. Try a different search term.
This is some text inside of a div block.
Anonymous
The Alta and John Franks Foundation
The Goodnow Fund
Ray and Dagmar Dolby Family Fund
The Sherrill Family
WoodNext Foundation
Teresa and Andrew Goodman
Frances and Nathan Kirsh
Linwood and Constance Lacy
The Lauder Foundation
Susan and Thomas Lowder
Linda Mirels
Ray and Kay Eckstein Charitable Trust
Glenn Sherrill, Jr.
Jeri and Mark Stenhouse
William Wright Family Foundation
Anonymous
Alisann and Terry Collins Foundation
Carol and Jack Aten
Ricki G. Conway
Doris & Stanley Tananbaum Foundation
Anne and Chris Flowers
Roz Goldstein
Nancy Goodes
Ann Jackson and Kendrick Wilson
Mitchell Kaneff
The Krehbiel Family Foundation
Elise and Marc Lefkowitz
The Malcolm Hewitt Wiener Foundation
Arely Murphy
Mary Jane and Carl Panattoni
Susan and Donald Sherrill
Stuart Sherrill
Wendy Wilshin and Ronald Dickerman
Laurence Zuriff
A.P. Kirby, Jr. Foundation, Inc.
Annette and Charles Cangro
Caryn J. Clayman
Joan and Ed Doherty
Jean and Ric Edelman
The Estée Lauder Companies Inc.
Caroline Fitzgibbons and Tad Smith
Estate of Evelyn H. Lauder
Beatrice Liu and Philip Lovett
Carlyn S. McCaffrey
Marie and Michael O'Reilly
John Paulson
Lois Robbins and Andrew Zaro
Round Pond Estate and the MacDonnell Family
Thomas Scanlan
Carol Seabrook Boulanger
Martha and Peter Webster
Carol and Michael Weisman
Anonymous
Bal Agrawal
Alexis Gregory Foundation
Hope and Marc Altheim
The Barry S. Sternlicht Foundation
Beacon Investment Advisory Services
Ellen and Alan Breed
Melanie and Louis Caceres
Chenel Capital
Lori and Anthony DiBarnaba
Laurie A. Dowley
Anne and Joel Ehrenkranz
Annette and Mitchell Eichen
Eisai, Inc.
Eli Lilly and Company
Filippo Berio
Claire Foerster and Daniel S. Bernstein
Stephanie and Ian Ginsberg
Agnes Gund
Janet Prindle Seidler Foundation
KLD Foundation
Deborah and Peter Krulewitch
L.C. Fulenwider Family
Marsha and Henry Laufer
Maria and Jorge Lazo
LifeWorx, Inc
Margaret and Daniel Loeb
Michelle MacDonald
Madison International Realty
Monumental Sports & Entertainment Foundation
Alicia and Stephen Nussdorf
Thomas Pheasant
Kathleen and Michael Pierce
The Randi & Clifford Lane Foundation Inc.
Robin and David Reis
Peggy Rice
Susan Slotkis
Diane and Thomas Smith
Joan Steinberg
Barbara and Donald Tober
Laura and Stephen Toma
Jennifer Vettel
David R. Weinreb
The Wolverine Foundation
Paula Zahn and Paul Fribourg
Anonymous
Caterina Alf
The Angelo Family Charitable Foundation
Christine and Max Ansbacher
Audrey & Martin Gruss Foundation
Martin Auerbach
Renée and Robert Belfer
Jill and Jay Bernstein
Raphael Bernstein
Michele and Lawrence Beyer
Lynn and Wolf Blitzer
Dr. Philip and Faith Bobrow
Susan and Jonathan Bram
The Buller Foundation
Mara and Steven Canner
Shelley and Michael Carr
Kristin and John Cecchi
Leila and David Centner
Cognition Therapeutics, Inc
Marcella and Neil Cohen
Michael T. Cohen
Crown Equipment Corporation
Dalia and Larry Leeds Family Foundation
Jeffrey Denard
James and Janet Dicke
Dorothy G. Bender Foundation
Cindy and Glen Edelman
Camille and Peter Edwards
Deborah and Steven Epstein
Katherine Farley and Jerry Speyer
Jerald D. Fessenden
Firmenich
Joel Florin
Franklin P. and Arthur W. Perdue Foundation, Inc.
The Garcia Family Spotlight Foundation
Jeffrey Gates and Richard Moran
David Gerson
Karen and Chuck Ghoorah
Elizabeth and Roger Gilmore
Givaudan
Julianna and Michael Goldman
Google
Elizabeth and Paul Greenbaum
Gloria Greenbaum
Laurie and Philip Gross
Marta Gucovsky and Edward Blank
Dena Henry
Pamela and Raymond Hill
The Howard B. Bernick Foundation
Howard Gilman Foundation
J.P. Morgan Chase & Co.
Kiera and Christopher Johnson
Helen and Stephen Judlowe
Katherine S. Kamen
Nancy Kestenbaum and David Klafter
Jana and Gerold Klauer
Peter Klosowicz
Candice Ku
Angela Kumble
Kurt & Gina Conti Family Foundation
Dana and Michael Landow
Laura Landro and Richard Salomon
Katherine and Joshua Lauder
Jonathan Leary
Ellen and Henry Levy
Susan Lloyd
Sharon and John Loeb
Andrea and Jeffrey Lomasky
Louis J. and June E.Kay Foundation
The Luminescence Foundation
Mandell and Madeleine Berman Foundation
Richard McClure
Susan and Ralph McCurdy
Julie Medler
Justin Meltzer
Robin and Roger Meltzer
Elaine and William Miller
Wayne M. Mincey
Cynthia S. Mincey
Neiman Marcus Tysons Galleria
Melanie and Lawrence Nussdorf
Michele and Robert O'Shea
Grant Osadchey
Parker O’Shea
Anna Marie Parisi-Trone and Robert Trone
Diane and Edward Powell
Cobey and Robert Rapaport
Jeff Rapaport
RAST Foundation
Jennifer Redmond
Lori and John Reinsberg
Jessica Resnick and Mitchell Babendir
Sharon and Daniel Roitman
Greg Rosica
Hilary and Wilbur Ross
Jamie Schlim
Lee Ann and Michael Scott
Diane and John Sculley
Carol and Michael Sesnowitz
Alice Shure
Michael Somenek
Toni and Martin Sosnoff
Steven C. Leuthold Family Foundation
Cindy and Laurence Tell
Alice and Richard Thall
Elizabeth and Jonathan Tisch
UsAgainstAlzheimer's
Ross Waller and Ann Marie Huebner
Missy and Joseph Walsh
Sara and John Walsh
Sandra Wegman and Steven Hurowitz
Renata and Alex Weiss
Janice Worth
Sorry, no donors found. Try a different search term.
The Abraham and Beverly Sommer Foundation
Albert B. Glickman Family Foundation
Barbara and Philip Altheim
Ayco Charitable Foundation
Willa and Robert Baynard
Lisa and Clifford Beek
Kunjlata Bhatt
Myra and Charles Biblowit
Tracey and Mark Bilski
Rochelle Bloom
David Blumenfeld
Evelyn T. Brandt
Margaret Brim Bewkes
Roberta Brinton
Ashley Bronczek
Lynda and F. Davis Camalier
Alice Cannon
Carolyn and Jeff Carney
Linda and Arthur Carter
The Corcoran Group
Cullen and Dykman LLP
Veronica and John DeBruin
Ira Deutsch
James DiPaula
Valerie and Charles Diker
Dolby Family Ventures
Douglas Durst
Robin D’Alessandro
Sarah Eastright
Eckert Seamans Cherin & Mellott, LLC
Susan and Paul Efron
Lynda Everman and Donald Wendorf
Phebe Farrow Port and Thomas David Port
Diane Finnerty
Michelle Florin
Debbie Forrest
Mary-Ann and Fabrizio Freda
Linda and Jay Freedman
Albert Fu
Barbara and Richard Furman
Cynthia and Christophor Galvin
Julie and Philip Geier
Sheri and David Gellman
Darby and J. Montgomery Gingery
Susan and Ronald Gold
Richard Golden
Marjorie and Ellery Gordon
Peter Gottsegen
Judy and James Harpel
Dede Harris
Theodore and Carol Hegg
Richard L. Hoffman
Aaron Hoyt
Chris Hutter
Sheryl and Chip Kaye
Vicki and Christopher Kellogg
Kelsey Family Foundation
Michele and Howard Kessler
Pamela Kimmet
Shelly and Howard Kivell
Susan and Robert Klein
Paulette Koch
Deborah and Stuart Lempert
Kristen and George Lund
Allison and Howard Lutnick
The Marc Haas Foundation
Susan and Morris Mark
Lauren Mason
Bonnie McElveen-Hunter and Giles Kemp
Gregory W. Meier
Anita and Sam Michaels
Bev and Marc Michel
Anne and Andrew Moller
Linda and Sidney Moskowitz
The Northern Trust Company
Richard D. Parsons
Edeltraut H. Patterson
Thomas Peterffy
Teresa Peterson
Bonnie Lynn Pfeifer Evans
Shannon Portell
Susanna and Jack Quinn
Judith and Kenneth Reiss
Wendy and Diego Reyes
Richters of Palm Beach
Cal and Kelly Ripken
Christine and Mark Roithmayr
Rebecca Rutledge Tweten
Sharon Sager and J. Loring Swasey
Saks Fifth Avenue
Edith and Gerald Schaeffer
Susan and Stephen Scherr
June and Paul Schorr
Patricia Silver and Leonard Ackerman
Joseph D. Simon
Donna Snow and Michael Rubinoff
South Dakota Trust Company LLC
Debbie and Craig Stapleton
Steve and Trish Shapiro Family Foundation
Bonnie and Thomas Strauss
Thompson Coburn LLP
Nassrine and Norman Traverse
The Tweten Foundation
Lorraine and Christopher Wallace
William and Jacqueline Shaw Family Foundation, Inc.
Nancy Yanofsky
Anonymous (3)
Carol Abend
Signey Adams
Bela Aggarwal
Stephanie Ahr
Abeer Al Otaiba and Ambassador Yousef
Alexandra William Foundation
Andrea and Allen Algaze
Gerness Alpert
Robby Altheim
Peter J. Anderson
Maureen and Richard Aneser
Michelle and Russ Appel
Catherine Applegate
The Ara D. Cohen Charitable Lead Trust
Louise Armour
Atelier Ashley Flowers
The Attilio and Beverly Petrocelli Family Foundation
Kerri Auito
Florence Auld
Amy and Brett Baier
Nevena Bailey
Barbara M. Baldwin
Jeffrey D. Banks
Barber Family Foundation
Carlton Bardel
Natalie Barth
Theresa Behrle-Mohs and Richard Mohs
Karen and Andrew Belfer
Baille Benemelis
Nancy and Brad Benjamin
Steven Berger
Howard and Judith Berkowitz
Toni and Seth Bernstein
Kathy and Gene Bernstein
Luke M. Beshar
Andi Black and Adam Brzostovski
Allison Blake
Sarah Bland
Anushka Blau
Alex Bloom
Bryan Bloom
Tina and Jeffrey Bolton
Bill Bone
Clare Bonsignore
Alexandra de Borchgrave
Merilee and Roy Bostock
Jacelyn and John Botti
Terry Boyer
Ron Bozman
Stacey Bradie and Todd Phillips
Bramshill Investments, LLC.
Emily Braun and Andrew Frackman
John Brecker
Patrice Brickman
Elena and John Brim
Lisa Brintz
Margaret Broekema
Vicki Brooks
Rhonda L. Brooks
Daniel Brownstein
Barbara Bryant
Nancy and Alan Bubes
Nora Burke
Jordan Burt
CTAD Congress
Jane and Calvin Cafritz
Debra Cahoon
Robert Calafiore
Rochelle and Jeffrey Canarick
Amy and Daniel Cantor
Ashley Carmen
Constance Carter
Anne Carullo
Paige and Andrew Charles
Gregory Chaskin
Ellie Christiansen
Peter Chu
Chong H. Chu-Stavins
Ramon Clements
Nicholas Coblence
Melanie Coburn
Beth and Jonathan Cohen
Rose H. Cohen
Debra and Edward Cohen
Allison Cohn
Ivy and Stephen Cohn
Cole Family Foundation
Jeanne Coleman
Sharon Collins Casey
Ellen Conley
Jennifer and Shane Connell
Jan and Lloyd Constantine
Joan and George Cook
Anita Cosgrove
Dale Coudert
Danielle Couick
John Covelli
Deborah Cowan
Helene and Gordon Crane
Michael C. Crowley
Hillary Cullen and Paul Bruder
Christina Cuomo Diver
Curated by Cecilia LLC
Stephanie Cutter
Ashley and Alan Dabbiere
Ann Danelski
Robert Danzi
The David & Sondra Mack Foundation, Inc.
Arthur DeGaetano
Mary Pat Dean
David A. Deckelbaum
Erin and Andrew Dickerman
Kevin J. Dieterich
Martha and Daniel Dippell
Amy Donnelly
Jamie and David Dorros
Deborah Doyle and Gordon Swartz
Terrence Drew
The Duber Family Foundation, Inc.
Jacquelyn and Kenneth Duberstein
Donna and Scott Dysert
Catherine Edwards
Jim Ehrke
Mary Ann Ehrlich
Adrienne Elrod
Susie and Edward Elson
Diana Epstein
Mary Kathleen Ernst and Edmund Spivack
Sara and Charles Fabrikant
Faegre Drinker Biddle & Reath LLP
Jessica Falkowitz
Harris Faulkner and Anthony Berlin
Chris Fawal
Matthew Fay
Sondra Fein Epstein
Susan Fink
Linda and Gregory Fischbach
Jordan Fitterman
Carey Flaherty
Linda and Mark Florin
Kathleen Ford
Audrey and James Foster
Monet Fraser
Sharon Fratepietro
Freitag Family Charitable Fund
Wendy Frieder
Cynthia Friedman
Diane Frimmel
Maria Galiani
Karen Galland and Roger Cohen
Kirsten Gargiulo
Richard Gargiulo
Douglas and Kerry Gatlin
Bill Gay
Caroline M. Geerlings and Samuel Metzger
The Geist Foundation
Cristina Genovese
Julia Ghafouri
Gary Gibson
Gilbert Giving Fund
Robin Gillen and Harvey Jones
Wendy Ginsberg
Laura Gladstone and Richard Kellner
Beth and James Glassman
Debby and Paul Glickman
Angela Goff
Ozerk Gogus
Mary and Jay Goldberg
David A. Goldberg
Cori and Sanford Goldfarb
Kara and Steven Goldman
Barry Goldstein
The Gould-Shenfeld Family Foundation
Alison Grann
Kenneth Gray
Jocelyn Greenan
Alyssa and Cliff Greenberg
Bonnie and Tod Greenfield
Tracey and Jeff Greenfield
Sharon and Rich Greenstein
Ashley Greer
Sharon and Ronald Grelsamer
Mae Grennan
Gropper Family Charitable Fund
Lynn and Andrew Gross
Dianne Grossman
Stanley Grossman
Robert Guiney
Louise F. Gunderson
Susan and John Gutfreund
Nada Hamadeh
Jill and Brad Hamburger
John Harkin
Fleur and Leonard Harlan
Josh Harlan
Jacqueline and Daniel Harman
Harman Family Foundation
Harold Plotnek Charitable Foundation
Ellen R. Harris
Steven Hason
Melinda and Thomas Hassen
Anne Hatfield Weir
Pamela and Thomas Heckel
Daniel Heider
Joni and Robert Henderson
Terrence Hendricks
Conner and Brad Herman
Thomas Hetzel
Carrie Hoernig
Robin Holtzman
Shelley and Jeff Holtzman
Gina Holzheimer
Shannon Hopkins
Suzanne S. Horn
Marybeth Howlett
Heidi K. Hubbard
Jane and Clifford Hudis
Lisa Iachetti
Joy H. Ingham
Marybeth and Tom Jacobson
Lois D. Jacobson
Olga Jaeckel
Annette Jaffe
Laurel and Spencer Jaffe
Amy and Scott Jaffee
Karen and Joseph Javitz
Donald Jenney
The John N. Blackman Sr. Foundation
Sydney Johnson
Cindy Jones
Craig Josephsen
Laurie and Marc Kahn
Ilana Kamber
Elayna and David Kaplan
Kaye Karch and Gerard Rubin
Sonia Kashuk and Daniel Kaner
Azali Kassum
Shari and Chanan Kaufman
Jennifer Kavounas
Kathleen and David Kelleher
Carolyn Keller
Christine L. Keller
Fiona Kelly
Eleanora Kennedy
Kent Consulting Engineers
Elise and Richard Kestenbaum
Karyn and Stephen Khoury
Belinda Kielland
Peter Kind
Kevin Kinsella
Jill S. Kirkpatrick
Rebecca Kirsch
Beth Kite
Francine and Edward Kittredge
Allison Kling
Diana and Israel Kogan
Susan and Martin Kravet
Nicole Kubin and Gerald Swartz
Joseph LaRosa
Susanna Lachs
Rachel Landau
Susan Landow
Lisabeth and Frederick Lane
Stacey and Curtis Lane
Phillip B. Lassiter
Carol and Francis LeCates
Jody and Dean Leavitt
Chris Leavitt
Steven Leber
Kathleen Legg
Lauren and John Legittino
Stefanie Lehmann
Alice Leiter
Hanane Lemlih
Thelma and Melvin Lenkin
Ilyse Lerner
Robin Levenson
Sarah and Ben Levine
Linda and Steven Levy
Jenny Libien and Richard Goodwin
Jean Lindenbaum
Jonnie Linn
Susan and Martin Lipton
Lisa Qian & Matthias Baenninger Giving Fund
Rose Liu
Callie Lohman
Ursula and Paul Lowerre
Stacey and Greg Lubar
Jose Luchsinger
Jonathan Lustig
Alisa and Walter Maher
Hildegarde Mahoney
Hyela Makoujy
Marlene Malek
Mina Malik
Michael Manasse
Jaime Marcus
Marex
Marna and Mitchel Margulis
Jill and Thomas Marino
Markel Corporation
Andrea Markezin and Joel Press
Stuart Martell
Gail and Alvin Martin
JoAnn and John Mason
Darren Massara
James McDonald
Roni and Charles McGuffog
Helen and Wayne McKeehan
David J. McMillin
Margaret M. Medler
Michael & Deborah Ratner Salzberg Family Foundation
Mariann Mihailidis
Todd Milano
Jennifer Millard
Elizabeth Miller
April and Robert Milman
Aja and Abdurezak Mohammed
Tamara and Richard Morgenstern
The Mosaic Foundation of Rita and Peter Heydon
Linda and David Moscow
Tyler Moser
Maria Mostajo and Mark Schein
Susan Mufson and Reid Chase
Mary Murphy
Patricia A. Murphy
Valerie Murray
Alex Nadasi
Bridget Nikodem
Fernanda Niven
Ellen C. O'Connell
Alyssa Olanoff
Orentreich Family Foundation
Cori and Kenny Orr
Michele and David Osterland
Candace Ourisman
Puja Parekh
Lindsey Parry Carzo
Jessica Pasik
Michael Passeroff
Amelia and Steven Paston
Susan and Alan Patricof
Tara Patten
Joan and Joseph Patton
Paul Soros Family Trust
Ilene and Arthur Penn
Elizabeth Perlman
Karen and Brian Perlman
Louise Pesale
Rocco Pesola
Adela Petrovic
Lisa and Michael Pfeffer
Ashley and Paul Pickard
Katherine Pirzadeh
Francis Podbielski
Lisa Pomerantz
Wendy Ponvert
Amy Porter
Lisa Porter
Muffie Potter Aston
Michael Punal
Arren Puri
Katherine Raber and Collin Hughes
Jaclyn Rapaport
Pouneh Razavi
Pamela and Carl Reimers
Leo Ressa
Clayton S. Reynolds
Randi and Dennis Riese
Bethany Ritchey
Lisa Ritter-Kahn
Molly Robb
Michelle and Michael Roberts
Rochelle & David A. Hirsch Foundation
Dana E. Rocks
Romanoff Equities Inc.
Rose Aiello Associates
Randi Rosenberg
Rachel and Michael Rosenberg
Lisa and Bradley Rosenberg
Stacey and Marc Rosenberg
Joan Rosenthal
Kevin M. Ryan
Edward Ryan
Stephen I. Sadove
Valerie Salembier and Paul Block
Emily Saltzman and David Hoffner
Carol Salzman and Michael Mann
Stacy and Kenneth Samet
Wendy B. Samuel
Laura Sanint Micolta
Lori and Phil Sarna
Rosita Sarnoff
Shadan Sayed Nasibdar
Judy and Vern Scacci
Timothy Scannell
Vicky and Mark Schattner
Nancy and Gerald Schattner
Jane and Larry Scheinfeld
Kathleen Schleckser
Ellen Schoninger
Aniko and Nash Schott
Steven Schroko
Erica R. Schwartz
Martin Schwartz
Robert Schwartz
Rose Schwartz
Douglas Seery
Karen and Chris Segal
Jamie Seidner and Jonathan Rubin
Derek Sells
Serota Development Company
Cherie and Daniel Serota
Mindy and Robert Setton
Laura and Gerald Shanley
Jean Sharf
Edwin A. Sheridan IV
Daniel Sherman
Eileen Shields-West
Randall Shu
Julie Siegel Padover and Michael Padover
Salman Sigari
Simon Paston & Sons
Paula Simon
Ryan Simpson
Suellen and Howard Singer
Jill and Sandy Sirulnick
Suzanne Slesin
Tina and Albert Small
Barbara and David Smith
Barbara K. Smith
Paul Smyth
Jose Solis
Lisa and Denis Somar
Amanda Somers
Maradel and George Sonnichsen
Daisy and Paul Soros
Thomas Soros
Ellen and Larry Sosnow
Constance and Stephen Spahn
Nancy and Richard Spelke
Bonnie and John Staffier
StataDX
Patricia Steele
Ried Stelly
Maria and Bryan Stepanian
Stephen M. Dowicz Foundation
David Stern
Marian and Jeff Stier
Lucy Stitzer
Robert Stone
Lila Sullivan
Daniel Sullivan
Andrew Sussman
Olivia Suter
Betsy and Charles Swersky
Lisa G. Tabak
Raymundo T. Tan
Cindy and Donald Tanenbaum
Nina Taselaar
Arlene Taub
Marc Teitelbaum
Leslie and Andrew Tell
Sandra and Jonathan Thackeray
Debra Therit
Andre Thomas
Julia Thomas
Cheryl Thorpe
Laura Thurman
Lynn and Peter Tishman
Ann Titelman Sullivan
Rachel and Robert Tobin
Judy Toma
Tommy Brull Foundation
Topgene Biotechnology Co., Ltd.
Kimberly Towers
Suzanne and Vincent Tufariello
Lisa and David Tuttle
Laura Tyson and Erik Tarloff
Shanee Uberman
Bronson Van Wyck
Velaro Incorporated
Barbara and Mark Vermylen
Victory Funds
Aaron Volosin
Von Graffenried Travel
Mary Walker
Mary and Kenneth Walker
Ellen and David Wasserman
The Waterfall Family Foundation
Tamara Watkins
Julie and Joe Watson
Emily Watts
Charlotte C. Weber
Margaret and Thomas Weber
Caryn Wechsler
Lisa Weiss
Marcie Weiss
Jacqueline Weissman
Caroline and Daniel Werther
Josh Wiener
Lise and Jeffrey Wilks
Seth Wilson
Barbara Winnik
Jillian Winoker
Patty Wisian-Nielsen
Jeanne Wolak
Lauren Wolfe
Lynne Wolitzer
Michelle and Peter Worth
Ilene and Alan Zack
Benjamin Zeliger
Robert Zizza
Sepe and Jason Zuccari
Daniela Zurbaran
Scroll

Our Boards

Governors
Overseers
Governors
Overseers

The Board of Governors is the principal board of the Corporation with all legal power and authority to manage, oversee, and make decisions regarding the ADDF’s programs and activities. Board members include leaders from government, industry, and the research community who serve as ambassadors for the ADDF and provide strategic oversight and counsel.

ADDF HONORARY CHAIR (RETIRED)
Justice Sandra Day O’Connor †
Associate Justice, US Supreme Court
ADDF CO-CHAIRS
Leonard A. Lauder
Chairman Emeritus, The Estée Lauder Companies Inc.
Ronald S. Lauder
Chairman, Clinique Laboratories, LLC
CO-VICE CHAIR AND SECRETARY
Randal Sandler
Director of Client Services and Marketing, Bridgewater Associates
EX OFFICIO
Howard Fillit, MD
Co-Founder and Chief Science Officer, Alzheimer’s Drug Discovery Foundation
CO-VICE CHAIR AND TREASURER
Thomas F. McWilliams
Private Investor, Retired Managing Partner, Court Square Capital Partners
* Honorary Members
† In Memoriam
Robert A. Belfer*
Chairman, Belfer Management
Niranjan Bose, PhD
Managing Director, Health & Life Sciences at Gates Ventures, LLC
Carol Seabrook Boulanger
Partner, Pillsbury, Winthrop, Shaw, and Pittman, LLP
Roberta Diaz Brinton, PhD
Inaugural Director of the Center for Innovation in Brain Science at the University of Arizona, Professor of Pharmacology and Neurology in the College of Medicine, Tucson
Nancy Corzine
President and CEO, Nancy Corzine Inc.
Ric Edelman
Founder, Digital Assets Council of Financial Professionals and Founder, The Truth About Your Future
Lanny Edelsohn, MD
Neurology Professor Emeritus, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia
Bonnie Pfeifer Evans
Senior Sales Associate, Corcoran Group Real Estate; Co-Trustee, The Charles Evans Foundation
Melvin R. Goodes†
Former Chairman and CEO, Warner-Lambert
Nancy Goodes
Former Executive, Nazareth-Century Mills; Secretary, Melvin R. Goodes Family Foundation, Inc.
Adam Hoffman
President, The Foundation For A Better World
Rachid Izzar
Executive Vice President, Global Product Strategy & Commercialization, Biogen Inc.
Ann Jackson
Philanthropist
Miia Kivipelto, MD, PhD
Professor of Clinical Geriatrics, Karolinska Institutet Center for Alzheimer Research, Senior Geriatrician and Director for Research and Development of Medical Unit Aging, Karolinska University Hospital
Gary M. Lauder
Managing Director, Lauder Partners LLC
Bonnie Englebardt Lautenberg
Photographer and Writer, Bonnie Lautenberg Designs
Laurence C. Leeds, Jr.
Chairman, Buckingham Capital Management, Inc.
Richard C. Mohs, PhD
Chief Science Officer, Global Alzheimer’s Platform Foundation
Sharon T. Sager, CIMA
Managing Director and Private Wealth Advisor, UBS Private Wealth Management
Philip Scheltens, MD, PhD
Partner & Head of the Dementia Fund, EQT Group, Amsterdam
Julieann Shanahan, CFA
Creator, Pavilion Living: Architecture, Patronage and Well-Being
Alice Shure
Founder and Producer, AMICI Productions LLC; Co-Trustee, The Charles Evans Foundation
Thomas S. (Tad) Smith, Jr
Chief Executive Officer and Director, TheKey
Laura Steele
Senior Vice President of US Neuroscience Business Unit, Eli Lilly
Sally Susman*
Executive Vice President, Policy, External Affairs and Communications, Pfizer Inc
David R. Weinreb
Chief Executive Officer, Weinreb Ventures
Paula Zahn
Host and Executive Producer, Discovery ID’s “On the Case with Paula Zahn,” and WNET’s “NYC Arts”
Henrik Zetterberg, MD, PhD
Professor of Neurochemistry and Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg and Clinical Chemist at Sahlgrenska University Hospital
Scroll
Governors
Overseers

The Board of Overseers is an advisory body committed to providing counsel and support to the ADDF Board of Governors and staff. Overseers lend their expertise to advance the ADDF's mission to accelerate the development of drugs to prevent, treat and cure Alzheimer’s disease. Overseers are appointed by and serve at the pleasure of the Board of Governors.

CHAIR
Christopher Johnson
President, Rackson Companies
Bal Agrawal
Founder and Chief Executive Officer, LifeWorx, Inc.; Founder and Chief Executive Officer, Prima Chefs, Inc.
Charles Cangro
Former Principal, Personal Financial Services, Ernst & Young, LLP
Kristin Rae Cecchi
Marketing Design Consultant, Cecchi Homes
Charlie Lefkowitz Crowley
Educational Consultant and Philanthropist
Mitchell D. Eichen, J.D., LL.M.
Founder and Chief Executive Officer, Acertus Capital ManagementFounder and Chief Executive Officer, The MDE Group
Phyllis Ferrell
Chief Impact Officer, Alzheimer's Moonshot, StartUp Health; Senior Consultant, Gates Ventures, LLC; Independent Advisor, PBFerrell, LLC
Joel Florin
President, Micro Essential Laboratory, Inc.
Dave Gerson
Personal Financial Planning Consultant, Retired Tax Partner Ernst & Young, LLC
Stephanie Ginsberg
Volunteer, Philanthropist; Founder, BCRF Pink Promises Benefit
Allan M. Green, MD, PhD, JD
Allan M. Green Esq., LLC
Gina F. Holzheimer
Vice President, J.P. Morgan Private Bank; Co-Founder and Co-Chair, ADDF Young Professionals Committee
Mitchell Kaneff
Chairman and Chief Executive Officer, Arkay
Josh Lauder
Co-Founder and Co-Chair, ADDF Young Professionals Committee
Elise Gelman Lefkowitz
Philanthropist
Philip Lovett
Founding Partner, Millennium Partners
Julie Medler
Managing Director, Golden Seeds
Justin Meltzer
Real Estate Operations, DLA Piper LLP
Phebe Farrow Port
Senior Vice President, Global Management Strategies and Chief of Staff, Executive Management Initiatives, The Estée Lauder Companies Inc.
Gregory A. Rosica
Partner, Tax, Ernst & Young, LLC
Tom Scanlan
Partner, Spencer Stuart
John H. Scully, CIMA
Senior Managing Director, Head of Private Wealth Advisory, Nuveen Investments
Stephen Toma
Managing Director, VJMS, LLC
Wendy L. Wilshin
Founder and Principal, WLW Designs
Scroll

Audited Financials

PDF (532 KB)

Form 990

PDF (972 KB)